1 / 73

Pharmacology Drug Absorption,Distribution & Elimination

Pharmacology Drug Absorption,Distribution & Elimination. Dr.Eby Isaac. Drugs: Agents that modify biological responses Transfer across cell membrane produce pharmacological response Cell Membrane: 10 nm wide bi molecular layer of phospholipid and protein. Lipid layer is regarded as fluid.

vivien-wade
Télécharger la présentation

Pharmacology Drug Absorption,Distribution & Elimination

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PharmacologyDrug Absorption,Distribution&Elimination Dr.Eby Isaac

  2. Drugs: • Agents that modify biological responses • Transfer across cell membrane produce pharmacological response • Cell Membrane: • 10 nm wide bi molecular layer of phospholipid and protein. Lipid layer is regarded as fluid.

  3. Extrinsic Proteins:- • Situated on the internal and external aspects of the membrane can be removed by pH and ionic changes • Intrinsic Proteins:- • Traverse entire width of the plasma membrane • From annulus surrounding small pores 0.5 nm in diameter • Act as enzymes or receptors • Mediate active transport of drugs

  4. Glycolipids & Glycoproteins :- • 5-10%, play a part in molecular recognition • Insulation:- • Potential difference across cell membranes facilitate transport through ionic channels

  5. Transfer of Drugs across Cell Membrane • Passive Process:- • Diffusion from higher to lower concentration gradient • Depends on • Concentration • Lipid solubility

  6. Drugs with high lipid aqueous partition coefficient means fast diffusion • Eg: Fentanyl, Diazepam • Drugs with low lipid aqueous partition coefficient means slow diffusion • Eg: Morphine

  7. A typical cell membrane

  8. Most drugs are weak acids or weak bases AH ⇌ A- + H+ ( for Acids) BH- ⇌ B + H+ ( for Bases)

  9. Non-iomic diffusion of the week acid AH (pKa= 6)

  10. In acid solutions AH and BH+ • In alkaline solutions A- and B • Non ionised form lipid soluble AH and B

  11. Henderson-Hesselbach’s Equation • pKa – pH = log [ AH ] [ A- ] • pKa value is a pH at which ionised and non-ionised forms of a drug are equal

  12. Basic Drug • B + H+⇌ BH+ • pKa – pH = log [ BH+] [ B ]

  13. Non-iomic diffusion of the weak base B (pKa=7)

  14. IV opioids Fentanyl & phenoperidines (weak bases) • Initial plasma conc. Decline followed by rise 30min. Later • Diffusion into stomach because of conc. Gradient • Subsequent absorption from small intestine

  15. Urine pH modification • Weak acids and bases present in ionic forms • Forced alkaline and acid diuresis • Limited applicability unless drugs are • Non protein bound • Confined to ECF • Eliminated unchanged in Urine

  16. Alkaline Diuresis:- • Salicylates and barbiturate poisoing • Acid Diuresis:- • Amphetamine, fenfluramine, Phencyclindine poisoing

  17. Carrier Transport of Drugs • Facilitated diffusion: • Faster than anticipated than their lipid solubility • Combination with specific sites on protein and conformational changes • Sugars, aminoacids & Pyramidines • L-Dopa absorbed by a carrier that normally transports aminoacids & flourouracil by pyramidine base transporter

  18. Active Transport • Cellular or Metabolic energy required • For Transfer across conc.gradient • by active transport of Na+ • Hydrolysis of ATP • Electrochemical gradient by Na+/ K+ ATPase • Drug + Protein transported across cell membrane • Active transport is saturable can be inhibited by other drugs • Active transport concerned with transfer of endogenous substance eg: reuptake of NA at sympathetic nerve endings coupled with Na+ transport

  19. Factors determining plasma conc. Of Drug • Absorption • Distribution • Metabolism • excretion

  20. Bioavailability: • Extent to which a drug reaches its site of action following administration • Estimated by comparing plasma conc. Of drug given by IV injection with levels obtained after administration of dose from which the drug must be absorbed ( pharmacokinetic analysis)

  21. Oral Administration • Most convenient • Non-compliance • Some drugs unstable in gastric fluid • Eg: Benzylpenicillin, erythromicin • Salicylates phenyl butazone irritate gastric mucosa • Circumvented by gastric coating, slow release • Plams conc. Time required 30-120 mts

  22. Adequate Plasma conc. Depend on • Dissolution • Absorption • Absence of significant first pass effects in gut wall or liver

  23. Drug Dissolution • Occurs usually in stomach • Dependent of gastric acidity • Gastric emptying • Absorbed mainly from upper part of small intestine • Factors effecting drug dissolution • Particle size • Chemical formulation • Inclusion of inert fillers • Outer coating applied

  24. Variation in Dissolution • Lactose excipient in diphenylhydantoin tablets cause toxicity • Difference in potency of digoxin tablets were traced to variations in the dissolution of different preparations

  25. Programmed or sustained oral Preparations • Erodable polymers • Greater convenience • Improved bioavailability • Less variation in plasma conc. • Decrease side effects • Decreased drug dosage • Decreased frequency of admn.

  26. Drug Absorption • Dependent on ability to penetrate • Non-ionised compounds • LMW substances readily absorbed eg; Urea, ethyl alcohol • Weakacids • Eg: Asprin, non-ionised in acidic conditions absorbed from stomach • Basic drugs • Eg: Propranolol, benzodiazepines less ionised in alkaline conditions absorbed from duodenum • Strong bases eg: Quarternary amines are always ionised not readily absorbed from gut

  27. Factors affecting Drug absorption • 1.Mucosal surface area. More in small intestine so both acids and bases absorbed from small intestine • 2.Non-ionised compounds and acidic drugs are absorbed from stomach so rapid increase in plasma conc. • 3.Compounds affecting gastric motility modify gastric absorption eg. Atropine and morphine decreased drug absorption

  28. Drugs absorption decreased in pathological conditions of GIT • Coeliac disease • Obstructive jaundice • After extensive resection of small intestine

  29. First Pass Effect • Metabolism by gutwall or liver • Gutwall-dopamine, Isoprenaline • Liver-lidocaine, Pethidine • When concentration in the hepatic vein<50% of portal vein – called high extraction ratio • Limited by liver blood flow • To avoid first pass effect drugs administered SL or PR • Propranolol reduce liver blood flow, so reduce first pass effect

  30. SC & IM Administration • For drugs broken down in the gut. Eg.Benzyl Pencilin, Polypetide hormones • Drugs with significant First Pass effect. Eg.Opioids • Intolerent to oral preparations. Eg. Iron salt • Patient compliance poor. Eg. Schizophrenia

  31. Factors Affecting Absorption • Dependant on regional blood flow. So IM route faster than SC route. • Not dependant on PH or dissociation constant • IV admn.- effects dependable & reproducable • Mini infusion pumps for intermittent drug delivery, syringe pumps, gravity methods.

  32. Other Routes • Mucous membranes, Eg. Conjunctive, nose, larynx, mucosal part of GIT. • Antibiotics, steroids are used for local effect • Buccal route for GTN, hyoscine, prochlor perazine. • Nasal route – for hypothalamic polypeptides-rapid absorption to CSF, submucous space in direct contact with subarchnoide space of olfactory lobes.

  33. Transdermal Absorption • Stratum corneum major barrior • Potent drugs with high lipid solubility absorbed. Eg. GTN, Fentanyl • Lidocaine, Prilocaine mixture EMLA • Tetracaine alone also used

  34. Intrathecal Administration • Local anesthetics • Analgesics • Antibiotics

  35. Inhalational Administration • Inhalational anesthetics – depends upon transfer from Alveoli to pul.capillaries. Steroids & Bronchodilators • Particles > 10 micro meter deposited URT • 2 to 10 microns deposited in bronchioles • < 2 microns reach alveoli

  36. Drug Distribution • Drug initially present in plasma partly bount to plasma proteins subsequently access tissues. • When ECF conc = plasma water conc.- distribution complete. • Distribution variable. Eg. Warfarin, Tolbutamide extremely protein bound. • Ionised compounds lithium cannot rapidly penetrate cell membrane, limited to ECF. Vol. D < 20L

  37. Lipid soluble drugs widely distributed us. Vol. D = total body water (30 – 45 L). • Morphine, STP, Digoxin penetrate cells bound to tissue proteins (Vol.D > 30 – 45L) • IV barbiturates rapidly redistributed from brain to muscle then to fat

  38. Drugs – Localised in tissues • Guanethidin – post ganglionicsymp: nerve endings • Iodine – thyroid gland • Sulph bromophthalein in liver • Tetracyclines in developing teeth & bone

  39. Blood Brain Barrier • Dynamic interface between blood and brain • Cerebral Capillary endothelial overlapping tight junctions restrict passive diffusion • Pinocytic vesicles are usually absent • Cerebral Capillary basement membrane closely applied to peripheral process of astrocytes. • Drugs have to cross 1) Endothelium, 2) Basement membrane 3) Peripheral process of astocytes. This is collectively called B.B.barrior (structural)

  40. Enzymatic or Metabolic B.B.Barrier • Associated with peripheral process of astrocytes • Neurotoxic substances. Eg. Ammonia, Freefatty acids are metobolized after crossing endothelium • MAO & Cholinestrases present in capillary endothelium • Drugs Eg. NA, Dopamine, local anestheticesters metabolised as they cross

  41. Metabolic substrates & hormones cross B.B.barrior by endocytosis or carrier transport. Eg. Glucose, insulin L-amino acids, L-thyroxine, transferin • LMW lipid soluble drugs local anesthetics, opioids, general anesthetics easily cross B.B. barrior • Highly protein bound drugs warfarin & tolbutamide only unbound fraction enter brain • Highly ionised cannot cross B.B. barrior so muscle relaxants do not enter brain

  42. Drugs cannot penetrate B.B. barrier unless there is inflammation, Edema, Hypertension. Eg. Benzyl penicillin in Meningitis • Area posterma, median eminence, pineal gland and choroid plexus are deficient in B.B. Barrier

  43. Placental Transfer • At term maternal & fetal blood compartment are separated by syncitiotrophoblast in continues contact with fetal capillaries • Behave like a lipid membrane • LMW lipid soluble drugs readily transferred • All drugs that cross B.B barrier cross placenta

  44. Factors affecting rate of transfer • Placental blood flow • Area available for diffusion • Magnitude of diffusion gradient

  45. Drugs causing fetal anomalies • Cyto-toxic agents • Folate antagonists • Phenytoin • Aminoglycoside antibiotics • Inhalational anesthetics • Barbiturates • Local anesthetics • Analgesics-morphine & pethidine

  46. Protein binding • Method of rapid distribution from site of absorption to site of action. • Lipid soluble drugs highly bound because not soluble in water. • Tissue perfusion causes unbound drug to decrease concentration so maintains a concentration gradient • Conce: in saliva & CSF reflects unbound drug level in plasma

  47. Globulins • Mainly bound to basic drugs Eg. Chlorpromazine, bupviccaine, opioid analgesics, vitamins, minerals, hormones. • Hydrocortsone

  48. Albumin Binds mainly neutral or acidic compounds • Salicylates, Phenylbutazone, indomethacine, Tolbutamide, anticoagulants, carbenaxolone • Some basic drugs and physiological substrates Bilirubin, fatty acids, tryptophan • dTc & Pancuronium bound to igG & albumine • Binding modified in hypoalbuminemia cirrohosis nephrosis

  49. Globulin Binding • Binds to basic drugs. Eg. Bupvicaine, Opioid • Hydrocortisone transported by transcortin • Resistance to muscle relaxants in liver disease due to extensive globulin binding • Alpha 1 acid like protein increased in MI, R.arthritis, renal failure, post surgery • So binding of basic drugs increased Eg. Propranolol

  50. Drug Metabolism • Conversion from lipid soluble drug to water soluble drug • Liver plays major part • Others are hydrolysed by plasma estrases • Gut chlorpromazine, isoprenaline • Kidney-midazolam, dopamine • Lung, angiotensin 1, Prilocine

More Related